Arbutus Biopharma Corporation ( ABUS ) is currently at $2.96, down $0.27 or 8.2%
--Would be lowest close since June 20, 2024, when it closed at $2.95
--On pace for largest percent decrease since April 25, 2023, when it fell 12.46%
--Currently down two consecutive days; down 15.53% over this period
--Worst two day stretch since the two days ending April 25, 2023, when it fell 15.67%
--Down 15.04% month-to-date
--Down 9.33% year-to-date
--Down 90.42% from its all-time closing high of $30.94 on March 11, 2014
--Down 4.05% from 52 weeks ago (April 8, 2024), when it closed at $3.09
--Down 34.98% from its 52-week closing high of $4.56 on Sept. 11, 2024
--Up 12.31% from its 52-week closing low of $2.64 on April 22, 2024
--Traded as low as $2.89; lowest intraday level since May 17, 2024, when it hit $2.89
--Down 10.53% at today's intraday low; largest intraday percent decrease since Aug. 5, 2024, when it fell as much as 11.65%
All data as of 11:17:43 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 07, 2025 11:20 ET (15:20 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。